Surgeons map better path for rare bile duct condition
NCT ID NCT07336576
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 234 adults with a rare bile duct condition called congenital biliary dilation, which can lead to serious health issues if not treated properly. Researchers developed a new way to classify the disease based on surgery needs, aiming to guide doctors in choosing the best operation—like removing part of the bile duct, liver transplant, or reconstruction. The goal is to improve long-term outcomes and reduce complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
surgery (bile duct removal, liver transplant, or bile duct reconstruction)
What this could lead to
If successful, this classification could help surgeons choose the best operation for each patient, potentially reducing long-term complications and cancer risk.
What could go wrong
This is a completed observational analysis, not a randomized trial, so the findings may not apply to all patients. Surgery carries risks like infection, bile leak, or liver problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL BILIARY DILATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Key Laboratory of Digital Intelligence Hepatology, Ministry of Education, School of Clinical Medicine, Tsinghua University, Beijing, China
Beijing, Beijing Municipality, 100000, China